Epstein-Barr virus early-antigen antibodies before allogeneic haematopoietic stem cell transplantation as a marker of risk of post-transplant lymphoproliferative disorders

British Journal of Haematology

Volumn 136, Issue 2, 2007, Pages 305-308

  Agbalika, Felix ^a   Larghero, Jerome ^a   Esperou, Helene ^a   Marais, Dominique ^a   Robin, Marie ^a   Foïs, Elena ^a   De Latour, Régis Peffault ^a   Gluckman, Eliane ^a   Rocha, Vanderson ^a   Benbunan, Marc ^a   Socié, Gerard ^a   Marolleau, Jean Pierre ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Allogeneic haematopoietic stem cell transplantation; Early antigen immunoglobulin G; Epstein Barr virus; Post transplant lymphoproliferative disorder

Indexed keywords

EARLY ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SEROLOGY; VIRUS LOAD;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL COUNT; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FANCONI ANEMIA; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROLOGIC TESTS; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD;

EID: 33845867958     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06420.x     Document Type: Article

References (12)

1. Carpentier, L., Tapiero, B., Alvarez, F., Viau, C. & Alfieri, C. (2003) Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease. Journal of Infectious Diseases, 188, 1853-1864.
2. Clave, E., Agbalika, F., Bajzik, V., de Latour, R.P., Trillard, M., Rabian, C., Scieux, C., Devergie, A., Socie, G., Ribaud, P., Ades, L., Ferry, C., Gluckman, E., Charron, D., Esperou, H., Toubert, A. & Moins-Teisserenc, H. (2004) Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy. Transplantation, 77, 76-84.
3. Curtis, R.E., Travis, L.B., Rowlings, P.A., Socie, G., Kingma, D.W., Banks, P.M., Jaffe, E.S., Sale, G.E., Horowitz, M.M., Witherspoon, R.P., Shriner, D.A., Weisdorf, D.J., Kolb, H.J., Sullivan, K.M., Sobocinski, K.A., Gale, R.P., Hoover, R.N., Fraumeni, Jr, J.F. & Deeg, H.J. (1999) Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood, 94, 2208-2216.
4. Gottschalk, S., Rooney, C.M. & Heslop, H.E. (2005) Post-transplant lymphoproliferative disorders. Annual Review of Medicine, 56, 29-44.
5. Kimura, H., Morita, M., Yabuta, Y., Kuzushima, K., Kato, K., Kojima, S., Matsuyama, T. & Morishima, T. (1999) Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. Journal of Clinical Microbiology, 37, 132-136.
6. Knowles, D.M., Cesarman, E., Chadburn, A., Frizzera, G., Chen, J., Rose, E.A. & Michler, R.E. (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood, 85, 552-565.
7. Leruez-Ville, M., Talbotec, C., Iserin, F., Salomon, R., Lecaille, F. & Rouzioux, C. (2004) Epstein-Barr virus (EBV) early-antigen antibodies and EBV DNA load in blood, in postransplantation lymphoproliferative disease. Journal of Infectious Diseases, 190, 1524-1525.
8. Pegtel, D.M., Middeldorp, J. & Thorley-Lawson, D.A. (2004) Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. Journal of Virology, 78, 12613-12624.
9. Pudney, V.A., Leese, A.M., Rickinson, A.B. & Hislop, A.D. (2005) CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells. Journal of Experimental Medicine, 201, 349-360.
10. Shapiro, R.S., McClain, K., Frizzera, G., Gajl-Peczalska, K.J., Kersey, J.H., Blazar, B.R., Arthur, D.C., Patton, D.F., Greenberg, G.S. & Burke, B. (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood, 71, 1234-1243.
11. Tao, Q., Ambinder, R.F. & Swinnen, L.J. (1998) Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance. American Journal of Pathology, 152, 1398-1399.
12. Wagner, H.J., Cheng, Y.C., Huls, M.H., Gee, A.P., Kuehnle, I., Krance, R.A., Brenner, M.K., Rooney, C.M. & Heslop, H.E. (2004) Prompt versus preemptive intervention for EBV lymphoproliferative disease. Blood, 103, 3979-3981.